Financials
- Market Capitalization 1.26 B
- Employee 56
- Founded 2011
- CEO N/A
- Website www.avalynpharma.com
- Headquarter Delaware, United States
- FIGI BBG003M9S3Z4
- Industry N/A
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2257 | EFOR Everforth, Inc. | 31.32 USD | +7.52% | -10.00% | -21.64% | +56.68% | 1.29 B USD | ||
| 2270 | YSWY Yesway, Inc. Class A Common Stock | 20.11 USD | +4.20% | -19.69% | -13.80% | -8.59% | 1.27 B USD | ||
| 2316 | DMC Del Monte Corporation | 24.9350 USD | -0.99% | -8.95% | -11.55% | -13.51% | 1.18 B USD | ||
| 2323 | CHRN ChronoScale Holdings Corporation Common Stock | 7.95 USD | -6.58% | -21.60% | -50.28% | -46.28% | 1.16 B USD |
Frequently asked questions about Avalyn Pharma Inc. Common Stock
What is the Avalyn Pharma Inc. Common Stock stock price today?
The current price of Avalyn Pharma Inc. Common Stock (AVLN) is 28.40. Over the past 24 hours, the stock has changed by -1.05%. Follow the AVLN chart for real-time price dynamics.
What is the stock ticker of Avalyn Pharma Inc. Common Stock?
Avalyn Pharma Inc. Common Stock trades under the ticker AVLN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Avalyn Pharma Inc. Common Stock stock going up?
AVLN has changed by -6.21% over the last week, +13.06% over the last month, and +9.23% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Avalyn Pharma Inc. Common Stock?
Avalyn Pharma Inc. Common Stock currently has a market capitalization of 1.26 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Avalyn Pharma Inc. Common Stock earnings last quarter?
Last quarter, Avalyn Pharma Inc. Common Stock reported earnings of -0.67 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Avalyn Pharma Inc. Common Stock revenue for the last quarter?
Avalyn Pharma Inc. Common Stock reported quarterly revenue of 3.2 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Avalyn Pharma Inc. Common Stock net income for the last quarter?
Avalyn Pharma Inc. Common Stock reported net income of -29.66 M for the last quarter. The previous quarter showed -28.93 M, which means net income changed by -2.49%.
How many employees does Avalyn Pharma Inc. Common Stock have?
As of the latest available data, Avalyn Pharma Inc. Common Stock has 56 employees. Workforce size can provide additional context about the company's scale and operations.
What is Avalyn Pharma Inc. Common Stock EBITDA?
Avalyn Pharma Inc. Common Stock EBITDA is -29.63 M, and its EBITDA margin is -925.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Avalyn Pharma Inc. Common Stock stock?
You can buy Avalyn Pharma Inc. Common Stock (AVLN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Avalyn Pharma Inc. Common Stock stock?
Investing in Avalyn Pharma Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AVLN chart and related analysis on metatrader.com as part of your research.